Aspire Biopharma Holdings reported total assets of $13.54M and total liabilities of $1.78M for the quarter ended Jun 2026. This balance sheet covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.62M | 0.58M | 0.53M | 0.50M | 0.32M | 0.13M | 0.25M | 0.01M | 0.05M | 0.02M | 0.02M | 0.00M | 1.35M | 0.25M | 1.95M | 1.00M | 5.86M | 12.17M | ||||
| Cash & Current Investments | 0.62M | 0.58M | 0.53M | 0.50M | 0.32M | 0.13M | 0.25M | 0.01M | 0.05M | 0.02M | 0.02M | 0.00M | 1.35M | 0.25M | 1.95M | 1.00M | 5.86M | 12.17M | ||||
| Receivables - OtherOther Receivables | 0.30M | 0.03M | 0.04M | |||||||||||||||||||
| Inventory | 0.04M | 0.25M | 0.37M | 0.29M | ||||||||||||||||||
| Prepaid Assets | 0.64M | 0.63M | 0.61M | 0.60M | 0.59M | 0.42M | 0.25M | 0.08M | 0.07M | 0.04M | 0.14M | 0.62M | 0.78M | 0.42M | 0.06M | 0.89M | 1.01M | |||||
| Current Assets | 0.29M | 1.26M | 1.21M | 1.15M | 1.10M | 0.91M | 0.55M | 0.25M | 0.08M | 0.07M | 0.34M | 0.15M | 1.97M | 0.99M | 2.40M | 1.31M | 7.12M | 13.47M | ||||
| Non-Current Assets | ||||||||||||||||||||||
| Long-Term Investments | 294.71M | 295.13M | 296.46M | 299.00M | 302.20M | 20.02M | 19.64M | 19.90M | 20.14M | 6.52M | 6.67M | |||||||||||
| Other Non-Current Assets | 0.53M | 0.38M | 0.23M | 0.08M | ||||||||||||||||||
| Non-Current Assets | 295.24M | 295.51M | 296.69M | 299.08M | 302.20M | 20.02M | 19.64M | 19.90M | 20.14M | 6.52M | 0.07M | |||||||||||
| Assets | 0.29M | 296.50M | 296.72M | 297.84M | 300.18M | 303.11M | 20.56M | 19.89M | 19.98M | 20.20M | 6.87M | 0.15M | 1.97M | 0.99M | 2.40M | 1.31M | 7.12M | 13.54M | ||||
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payables | 273.00 | 0.02M | 0.08M | 0.10M | 0.18M | 0.20M | 0.10M | 0.10M | 0.15M | 0.37M | 0.58M | 0.31M | 1.43M | 1.35M | 1.06M | 1.01M | 0.86M | 0.97M | ||||
| Notes Payables | 0.24M | 0.01M | 0.22M | 0.43M | 0.44M | 1.27M | 1.21M | 1.33M | 3.55M | 0.04M | ||||||||||||
| Payables | 0.24M | 0.02M | 0.08M | 0.10M | 0.18M | 0.20M | 0.10M | 0.10M | 0.16M | 0.58M | 1.01M | 0.44M | 1.58M | 2.64M | 2.68M | 4.62M | 1.06M | 0.86M | 0.97M | |||
| Accumulated Expenses | 0.32M | 0.38M | 0.27M | 1.01M | 0.44M | 0.71M | ||||||||||||||||
| Other Accumulated Expenses | 0.12M | 0.18M | 0.21M | 0.24M | 0.27M | 0.30M | 0.11M | 0.35M | 0.35M | 0.35M | 0.35M | 0.35M | ||||||||||
| Short term Debt | 0.01M | 0.22M | 4.93M | 4.90M | 13.76M | 3.18M | 3.62M | 4.74M | 1.50M | 0.50M | ||||||||||||
| Current Taxes | 0.03M | 0.06M | 0.09M | 0.12M | 0.15M | |||||||||||||||||
| Total Current Liabilities | 0.29M | 0.05M | 0.15M | 0.19M | 0.30M | 0.36M | 0.28M | 0.32M | 0.40M | 2.63M | 6.24M | 1.69M | 9.87M | 10.56M | 13.86M | 7.59M | 3.15M | 1.69M | ||||
| Non-Current Liabilities | ||||||||||||||||||||||
| Non-Current Debt | 0.36M | 0.50M | 0.50M | 1.50M | ||||||||||||||||||
| Non-Current Deffered Revenue | 10.81M | 5.00M | 5.00M | 10.81M | 10.81M | 5.00M | 5.00M | 10.81M | 5.00M | |||||||||||||
| Preferred Stock Liabilities | 294.69M | 295.13M | 296.46M | 299.00M | 302.20M | 20.02M | 19.64M | 19.90M | 20.14M | 6.52M | 6.67M | |||||||||||
| Other Non-Current Liabilities | 0.16M | 0.45M | 0.45M | 0.45M | 0.50M | 1.88M | 2.03M | 0.04M | ||||||||||||||
| Total Non-Current Liabilities | 11.12M | 0.32M | 0.25M | 2.18M | 5.79M | 0.33M | 1.19M | 8.04M | 8.58M | 7.65M | ||||||||||||
| Total Liabilities | -280.00 | 0.29M | 10.86M | 10.96M | 11.00M | 11.12M | 11.17M | 0.28M | 0.32M | 0.40M | 2.63M | 6.24M | 0.77M | 1.69M | 9.92M | 10.61M | 13.87M | 7.69M | 3.25M | 1.78M | ||
| Shareholder's Equity | ||||||||||||||||||||||
| Total Debt | 0.24M | 0.39M | 0.43M | 5.36M | 5.84M | 15.53M | 4.39M | 4.95M | 8.29M | 3.04M | 0.50M | |||||||||||
| Common Equity | 280.00 | -475.00 | -9.05M | -9.37M | -9.62M | -9.94M | -10.26M | 0.26M | -0.06M | -0.49M | -0.49M | -0.56M | -0.77M | -1.54M | -7.95M | -9.62M | -11.47M | -6.38M | 3.87M | 11.76M | ||
| Liabilities and Shareholders Equity | 0.29M | 296.50M | 296.72M | 297.84M | 300.18M | 303.11M | 20.56M | 19.89M | 19.98M | 20.20M | 6.87M | 0.15M | 1.97M | 0.99M | 2.40M | 1.31M | 7.12M | 13.54M | ||||
| Retained Earnings | -0.03M | -9.05M | -9.37M | -9.62M | -9.94M | -10.26M | 10.81M | -10.88M | -11.29M | -13.99M | -14.76M | -2.78M | -18.72M | -20.70M | -22.55M | -27.26M | 34.35M | 43.51M | ||||
| Preferred Shares | 5.00M | 5.00M | 32.00 | 1.00 | 2.00 | |||||||||||||||||
| Treasury Shares | 28.75M | 28.75M | 1.80M | 1.80M | 1.80M | 1.80M | 0.58M | 0.58M | 0.58M |